Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer

Clinical trial NCT01582191 · COMPLETED

Trial details

NCT number: NCT01582191
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Neoplasm Metastatic Malignant Neoplasm Recurrent Malignant Neoplasm Refractory Malignant Neoplasm

Start date: 2012-05-14
Primary completion: 2025-10-22
Enrollment: 151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.